X Inactivation and Genomic Imprinting: Epigenetic Gene Regulation

Added:

The Transcription Factor-Centric Model of Gene Regulation

While textbook models often present epigenetic mechanisms—such as DNA methylation and histone modifications—as primary drivers of gene regulation and dosage control, a significant counter-perspective argues that these marks are secondary consequences rather than causes of gene expression. This 'transcription factor-centric' view posits that sequence-specific transcription factors first bind to DNA and recruit chromatin-remodeling complexes, meaning genetic sequence and transcription machinery drive the regulatory state. Under this model, epigenetic modifications like those seen in X-inactivation and genomic imprinting serve as stabilizing, downstream 'cellular memory' marks to maintain expression states, rather than active upstream regulators. This distinction is crucial for understanding disease mechanisms, suggesting that therapeutic interventions should target genetic regulators and transcription factors rather than epigenetic writers and erasers.

Basic principles of Mendelian genetics, including dominant and recessive alleles and typical inheritance patterns.
The structure of chromosomes and the mechanism of mammalian sex determination (XX vs. XY).
The central dogma of molecular biology, specifically how genes are transcribed into RNA and translated into proteins.
An introductory understanding of epigenetic modifications, such as DNA methylation and histone acetylation, which alter gene expression without changing the underlying DNA sequence.
Specific genetic disorders arising from genomic imprinting defects, such as Prader-Willi Syndrome, Angelman Syndrome, and Beckwith-Wiedemann Syndrome.
The molecular mechanisms of long non-coding RNAs (lncRNAs), specifically how Xist and Tsix coordinate the silencing of the inactive X chromosome.
Comparative dosage compensation strategies across different species, such as Drosophila melanogaster and Caenorhabditis elegans.
The role of epigenetic reprogramming during embryonic development and the maintenance of pluripotency in stem cells.
The contribution of aberrant imprinting (loss of imprinting) and epigenetic alterations to oncogenesis and cancer progression.
772 views15likes27:29@lisajohansen1868Original Release: 2018-10-07

X chromosome inactivation and genomic imprinting are two critical epigenetic mechanisms that ensure proper gene dosage compensation in mammals. X-inactivation involves the XIST long non-coding RNA coating one X chromosome to silence most genes, creating a Barr body, while the active X expresses Tsix to block XIST; this random process occurs during early embryonic development and creates cellular mosaicism in females. Genomic imprinting involves monoallelic expression where specific genes are silenced from either the maternal or paternal chromosome based on parent-of-origin, with imprinted genes organized in clusters controlled by enhancers and insulators. Both mechanisms involve histone modifications and DNA methylation to regulate gene expression without altering DNA sequence, and both undergo erasure and re-establishment in germ cells to maintain proper gene dosage across generations.